Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study

• Published in: Cardiovascular diabetology Vol. 19; no. 1; pp. 45 - 10
• Main Authors: Jin, Jing-Lu, Zhang, Hui-Wen, Cao, Ye-Xuan, Liu, Hui-Hui, Hua, Qi, Li, Yan-Fang, Zhang, Yan, Wu, Na-Qiong, Zhu, Cheng-Gang, Xu, Rui-Xia, Gao, Ying, Li, Xiao-Lin, Cui, Chuan-Jue, Liu, Geng, Sun, Jing, Dong, Qian, Guo, Yuan-Lin, Li, Jian-Jun
• Format: Journal Article
• Language: English
• Published: England BioMed Central 03.04.2020; BMC
• Subjects: Angina pectoris; Automation; Blood glucose; Blood pressure; Body mass index; CAD, DM; Cardiovascular disease; Cholesterol; Cohort analysis; Coronary artery; Coronary vessels; Diabetes; Diabetes mellitus; Family medical history; Fasting; Glucose metabolism; Heart attacks; Heart diseases; Hypertension; Laboratories; Lipoproteins; MACEs; Medical prognosis; Observational studies; Original Investigation; Physicians; Regression analysis; Risk factors; sdLDL; Studies; Japan; sdLDL; CAD, DM; MACEs
• ISSN: 1475-2840; 1475-2840
• DOI: 10.1186/s12933-020-01015-6

Elevation in small dense low-density lipoprotein (sdLDL) is common in patients with diabetes mellitus (DM), which has already been reported to be associated with incidence of coronary artery disease (CAD). The aim of the present study was to investigate the prognostic value of plasma sdLDL level in patients with stable CAD and DM. A total of 4148 consecutive patients with stable CAD were prospectively enrolled into the study and followed up for major cardiovascular events (MACEs) up to 8.5 years. Plasma sdLDL level was measured in each patient by a direct method using automated chemistry analyzer. The patients were subsequently divided into four groups by the quartiles of sdLDL and the association of sdLDL level with MACEs in different status of glucose metabolism [DM, Pre-DM, normal glycaemia regulation (NGR)] was evaluated. A total of 464 MACEs were documented. Both Kaplan-Meier analysis and Cox regression analysis indicated that the patients in quartile 4 but not quartile 2 or 3 of sdLDL level had significantly higher rate of MACEs than that in lowest quartile. When the prognostic value of high sdLDL was assessed in different glucose metabolism status, the results showed that the high sdLDL plus DM was associated with worse outcome after adjustment of confounding risk factors (hazard ratio: 1.83, 95% confident interval: 1.24-2.70, p < 0.05). However, no significant association was observed for high sdLDL plus Pre-DM or NGR. The present study firstly indicated that elevated levels of plasma sdLDL were associated with increased risk of MACEs among DM patients with proven CAD, suggesting that sdLDL may be useful for CAD risk stratification in DM.